NEWS SUMMARY: ACS. Ibex ended last week with daily gains Last week ended without relevant corporate results or macroeconomic data and with the implementation of tariff not entailing market volatility. The focus will now be on the US inflation (Tuesday) and peace talks in Ukraine between the US and Russia (Friday). The Ibex registered the best week in the past 4 months, ending above 14,800 points, returning to annual highs and near 2007 highs. Thus, in the STOXX 600 almost all sectors (16/20) en...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS. EUROPA: VINCI. El Ibex cierra un pleno de subidas semanal Terminó la semana sin datos macro ni resultados empresariales de relevancia, y sin que la entrada en vigor de los aranceles trajera volatilidad a los mercados. Ahora toda la atención estará en la inflación en EE.UU. (martes) y las conversaciones de paz en Ucrania entre EE.UU. y Rusia (viernes). El Ibex cerró su mejor semana en 4 meses, renovando máximos anuales por encima de los 14.800 p...
NEWS SUMMARY: N/A. European markets ignore D. Trump D. Trump’s latest threats to the euro zone through higher tariffs did not have any impact on stock markets, which continued to climb as seen earlier this week, with the Ibex hitting again 2008 highs. Thus, in the STOXX 600 Energy and Real Estate saw the biggest gains vs. Pharma and Technology that were the worst performers. On the macro side, in the euro zone, June’s retail sales climbed more than expected. In Germany, June’s factory orders s...
Two Directors at International Consolidated Airlines Group SA sold 150,000 shares at between 371p and 378p. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
Rdos. 2T'25 vs 2T'24: Ventas: 8.862 M euros (+6,8% vs +6,3% BS(e)); EBIT: 1.680 M euros (+35,4% vs +15,1% BS(e) y +15,2% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 15.906 M euros (+8,0% vs +7,7% BS(e)); EBIT: 1.878 M euros (+43,5% vs +24,2% BS(e) y +24,4% consenso).
2Q'25 vs. 2Q'24 Results Sales: € 12.318 Bn (+22.7% vs. +23.4% BS(e) and +18.4% consensus); EBITDA: € 735.0 M (+5.6% vs. +5.3% BS(e) and +5.7% consensus); EBIT: € 472.0 M (-1.7% vs. -2.6% BS(e) and +0.4% consensus); Net Profit: € 259.0 M (+8.4% vs. -20.7% BS(e) and -18.9% consensus); 1H'25 vs. 1H'24 Results Sales: € 24.108 Bn (+28.6% vs. +29.0% BS(e) and +26.3% consensus); EBITDA: € 1.434 Bn (+23.9% vs. +23.7% BS(e) and +24.0% consensus); EBIT: € 942.0 M (+16.7% vs. +16.2% BS(e) and +18.0% consen...
Rdos. 2T'25 vs 2T'24: Ventas: 12.318 M euros (+22,7% vs +23,4% BS(e) y +18,4% consenso); EBITDA: 735,0 M euros (+5,6% vs +5,3% BS(e) y +5,7% consenso); EBIT: 472,0 M euros (-1,7% vs -2,6% BS(e) y +0,4% consenso); BDI: 259,0 M euros (+8,4% vs -20,7% BS(e) y -18,9% consenso); Rdos. 1S'25 vs 1S'24: Ventas: 24.108 M euros (+28,6% vs +29,0% BS(e) y +26,3% consenso); EBITDA: 1.434 M euros (+23,9% vs +23,7% BS(e) y +24,0% consenso); EBIT: 942,0 M euros (+16,7% vs +16,2% BS(e) y +18,0% consenso); BDI: 4...
2Q'25 vs. 2Q'24 Results Sales: € 2.41 Bn (+0.9% vs. +3.3% BS(e) and +3.8% consensus); EBITDA: € 346.0 M (-0.9% vs. +7.9% BS(e) and +9.2% consensus); EBIT: € 232.0 M (-41.9% vs. -34.3% BS(e) and -32.8% consensus); 1H'25 vs. 1H'24 Results Sales: € 4.469 Bn (+4.7% vs. +6.1% BS(e) and +6.3% consensus); EBITDA: € 655.0 M (+8.6% vs. +13.7% BS(e) and +14.4% consensus); EBIT: € 431.0 M (-21.8% vs. -16.3% BS(e) and -15.2% consensus); Net Profit: € 540.0 M;
Rdos. 2T'25 vs 2T'24: Ventas: 2.410 M euros (+0,9% vs +3,3% BS(e) y +3,8% consenso); EBITDA: 346,0 M euros (-0,9% vs +7,9% BS(e) y +9,2% consenso); EBIT: 232,0 M euros (-41,9% vs -34,3% BS(e) y -32,8% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 4.469 M euros (+4,7% vs +6,1% BS(e) y +6,3% consenso); EBITDA: 655,0 M euros (+8,6% vs +13,7% BS(e) y +14,4% consenso); EBIT: 431,0 M euros (-21,8% vs -16,3% BS(e) y -15,2% consenso); BDI: 540,0 M euros (n/a vs n/a BS(e) y n/a consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAIXABANK, FERROVIAL, GRIFOLS, REDEIA, SACYR, SANTANDER, TALGO, TELEFÓNICA. EUROPA: ADIDAS, DANONE, KERING, L’ORÉAL, MERCEDES BENZ GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Los resultados toman el relevo Recuperación marcada por el...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.